23 May2024Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted TherapiesAuthor By Healthufit Posted on May 23, 2024May 23, 2024Nona Biosciences Announces Global License and Option Agreement with AstraZe...